Showing 1 – 20 of 76
Relevance | Newest | Oldest |
  • Lutein/Zeaxanthin for the Treatment of Age-Related Cataract: AREDS2 Randomized Trial Report No. 4

    Abstract Full Text
    free access is expired quiz
    JAMA Ophthalmol. 2013; 131(7):843-850. doi: 10.1001/jamaophthalmol.2013.4412

    The Age-Related Eye Disease Study 2 (AREDS2) Research Group conducted a multicenter, double-masked clinical trial to determine whether daily oral supplementation with lutein/zeaxanthin affects the risk for cataract surgery.

  • Oral Nutrient Supplementation and Cognitive Function—Reply

    Abstract Full Text
    JAMA. 2016; 315(5):516-517. doi: 10.1001/jama.2015.16467
  • Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial

    Abstract Full Text
    JAMA Ophthalmol. 2018; 136(8):849-856. doi: 10.1001/jamaophthalmol.2018.1171

    This randomized clinical trial evaluates the potential efficacy and assesses the safety of orally administered valproic acid in the treatment of autosomal dominant retinitis pigmentosa.

  • Genetic Penetrance of Macular Telangiectasia Type 2

    Abstract Full Text
    JAMA Ophthalmol. 2018; 136(10):1158-1163. doi: 10.1001/jamaophthalmol.2018.3283

    This cross-sectional study aims to determine the genetic penetrance of macular telangiectasia type 2 (MacTel) in parents and siblings of affected families.

  • Choroideremia in a Woman With Turner Syndrome

    Abstract Full Text
    JAMA Ophthalmol. 2018; 136(9):1076-1078. doi: 10.1001/jamaophthalmol.2018.2630

    This case report describes a 67-year-old woman with a fully expressed form of choroideremia due to coexistent Turner syndrome.

  • A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's Disease

    Abstract Full Text
    JAMA. 1994; 271(13):985-991. doi: 10.1001/jama.1994.03510370037029
  • Crystalline Maculopathy Associated With High-Dose Lutein Supplementation

    Abstract Full Text
    JAMA Ophthalmol. 2016; 134(12):1445-1448. doi: 10.1001/jamaophthalmol.2016.4117

    This case report describes crystalline maculopathy associated with high-dose lutein supplementation.

  • Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial

    Abstract Full Text
    free access is expired quiz
    JAMA. 2015; 314(8):791-801. doi: 10.1001/jama.2015.9677

    This randomized trial reports that among older individuals with age-related macular degeneration supplements containing long-chain fatty acids and/or lutein and zeaxanthin had no effect on cognitive function.

  • Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use With MF59 Adjuvant: A Randomized Clinical Trial

    Abstract Full Text
    free access
    JAMA. 2014; 312(14):1409-1419. doi: 10.1001/jama.2014.12854

    This randomized trial reports point-of-use mixing and administration of 2 doses of H7N9 vaccine at the lowest tested antigen dose with MF59 adjuvant, producing seroconversion in participants.

  • Hospital Performance for Pharmacologic Venous Thromboembolism Prophylaxis and Rate of Venous Thromboembolism: A Cohort Study

    Abstract Full Text
    free access
    JAMA Intern Med. 2014; 174(10):1577-1584. doi: 10.1001/jamainternmed.2014.3384

    Flanders and coauthors examine the association between pharmacologic venous thromboembolism prophylaxis rates and hospital-associated venous thromboembolism.

  • Detection of Cervical Human Papillomavirus by Molecular Probes

    Abstract Full Text
    JAMA. 1990; 264(4):453-453. doi: 10.1001/jama.1990.03450040041019
  • Temporal Macular Thinning Associated With X-Linked Alport Syndrome

    Abstract Full Text
    free access
    JAMA Ophthalmol. 2013; 131(6):777-782. doi: 10.1001/jamaophthalmol.2013.1452
    Ahmed et al correlate optical coherence tomography findings and severity of temporal macular thinning with COL4A5 mutations in a cohort with X-linked Alport syndrome.
  • Shapes of the Trajectories of 5 Major Biomarkers of Alzheimer Disease

    Abstract Full Text
    free access
    Arch Neurol. 2012; 69(7):856-867. doi: 10.1001/archneurol.2011.3405
    Using longitudinal registries from the Mayo Clinic and the Alzheimer’s Disease Neuroimaging Initiative, Jack et al characterize the shape of the trajectories of Alzheimer disease biomarkers as a function of Mini-Mental State Examination score.
  • Quantification of Macular Carotenoids Using Autofluorescence Imaging in Patients With Photosensitive Migraine and Benign Essential Blepharospasm

    Abstract Full Text
    free access
    Arch Ophthalmol. 2012; 130(2):259-260. doi: 10.1001/archopthalmol.2011.1372
  • Evidence for Ordering of Alzheimer Disease Biomarkers

    Abstract Full Text
    free access
    Arch Neurol. 2011; 68(12):1526-1535. doi: 10.1001/archneurol.2011.183
  • Assessing Susceptibility to Age-Related Macular Degeneration With Genetic Markers and Environmental Factors

    Abstract Full Text
    free access
    Arch Ophthalmol. 2011; 129(3):344-351. doi: 10.1001/archophthalmol.2011.10
  • Impact of a Pharmacist-Facilitated Hospital Discharge Program: A Quasi-Experimental Study

    Abstract Full Text
    free access
    Arch Intern Med. 2009; 169(21):2003-2010. doi: 10.1001/archinternmed.2009.398
  • Association of Adipose and Red Blood Cell Lipids With Severity of Dominant Stargardt Macular Dystrophy (STGD3) Secondary to an ELOVL4 Mutation

    Abstract Full Text
    free access
    Arch Ophthalmol. 2006; 124(2):257-263. doi: 10.1001/archopht.124.2.257
  • Optical Coherence Tomography Before and After Repair of a Macular Hole Induced by an Unintentional Argon Laser Burn

    Abstract Full Text
    Arch Ophthalmol. 2005; 123(3):404-405. doi: 10.1001/archopht.123.3.404
  • Subcutaneous Emphysema and Pneumomediastinum Complicating Tonsillectomy

    Abstract Full Text
    Arch Otolaryngol Head Neck Surg. 2004; 130(11):1324-1327. doi: 10.1001/archotol.130.11.1324